264 related articles for article (PubMed ID: 16930005)
1. Molecular and genetic aspects of DiGeorge/velocardiofacial syndrome.
Driscoll DA
Methods Mol Med; 2006; 126():43-55. PubMed ID: 16930005
[TBL] [Abstract][Full Text] [Related]
2. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
3. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite DNA markers detects 95% of chromosome 22q11 deletions.
Bonnet D; Cormier-Daire V; Kachaner J; Szezepanski I; Souillard P; Sidi D; Munnich A; Lyonnet S
Am J Med Genet; 1997 Jan; 68(2):182-4. PubMed ID: 9028455
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
Ravnan JB; Chen E; Golabi M; Lebo RV
Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization.
Lindsay EA; Halford S; Wadey R; Scambler PJ; Baldini A
Genomics; 1993 Aug; 17(2):403-7. PubMed ID: 8406492
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Registry screening for DiGeorge Critical Region deletion using loss of heterozygosity analysis.
Katzman PJ; Smoot LB; Cox GF
Pediatr Dev Pathol; 2006; 9(4):266-79. PubMed ID: 16944986
[TBL] [Abstract][Full Text] [Related]
8. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
[TBL] [Abstract][Full Text] [Related]
9. Altered replication timing of the HIRA/Tuple1 locus in the DiGeorge and Velocardiofacial syndromes.
D'Antoni S; Mattina T; Di Mare P; Federico C; Motta S; Saccone S
Gene; 2004 May; 333():111-9. PubMed ID: 15177686
[TBL] [Abstract][Full Text] [Related]
10. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of 22q11 microdeletion.
Levy-Mozziconacci A; Piquet C; Heurtevin PC; Philip N
Prenat Diagn; 1997 Nov; 17(11):1033-7. PubMed ID: 9399351
[TBL] [Abstract][Full Text] [Related]
12. DiGeorge syndrome: new insights.
Goldmuntz E
Clin Perinatol; 2005 Dec; 32(4):963-78, ix-x. PubMed ID: 16325672
[TBL] [Abstract][Full Text] [Related]
13. Computational analysis and refinement of sequence structure on chromosome 22q11.2 region: application to the development of quantitative real-time PCR assay for clinical diagnosis.
Chen YF; Kou PL; Tsai SJ; Chen KF; Chan HH; Chen CM; Sun HS
Genomics; 2006 Feb; 87(2):290-7. PubMed ID: 16307865
[TBL] [Abstract][Full Text] [Related]
14. Kabuki syndrome is not caused by a microdeletion in the DiGeorge/velocardiofacial chromosomal region within 22q 11.2.
Li M; Zackai EH; Niikawa N; Kaplan P; Driscoll DA
Am J Med Genet; 1996 Oct; 65(2):101-3. PubMed ID: 8911598
[TBL] [Abstract][Full Text] [Related]
15. Deletion 22q11: spectrum of associated disorders.
Hay BN
Semin Pediatr Neurol; 2007 Sep; 14(3):136-9. PubMed ID: 17980310
[TBL] [Abstract][Full Text] [Related]
16. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions. A review.
Demczuk S; Aurias A
Ann Genet; 1995; 38(2):59-76. PubMed ID: 7486827
[TBL] [Abstract][Full Text] [Related]
17. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
[TBL] [Abstract][Full Text] [Related]
18. Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2: report of five families with a review of the literature.
Leana-Cox J; Pangkanon S; Eanet KR; Curtin MS; Wulfsberg EA
Am J Med Genet; 1996 Nov; 65(4):309-16. PubMed ID: 8923941
[TBL] [Abstract][Full Text] [Related]
19. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome.
Guris DL; Fantes J; Tara D; Druker BJ; Imamoto A
Nat Genet; 2001 Mar; 27(3):293-8. PubMed ID: 11242111
[TBL] [Abstract][Full Text] [Related]
20. Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2).
Schuffenhauer S; Lichtner P; Peykar-Derakhshandeh P; Murken J; Haas OA; Back E; Wolff G; Zabel B; Barisic I; Rauch A; Borochowitz Z; Dallapiccola B; Ross M; Meitinger T
Eur J Hum Genet; 1998; 6(3):213-25. PubMed ID: 9781025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
